.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01D_OtherBetaLactamAntibacterials.J01DD15_Cefdinir.Cefdinir .Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01D_OtherBetaLactamAntibacterials.J01DD15_Cefdinir.Cefdinir| name: | Cefdinir |
| ATC code: | J01DD15 | route: | oral |
| n-compartments | 1 |
Cefdinir is a third-generation oral cephalosporin antibiotic used for the treatment of a variety of bacterial infections including community-acquired pneumonia, bronchitis, sinusitis, pharyngitis, and certain skin infections. It is currently approved and commonly prescribed for both adults and children.
Single-dose pharmacokinetic parameters in healthy adult volunteers, following oral administration.
Guay, DR (2000). Pharmacodynamics and pharmacokinetics of cefdinir, an oral extended spectrum cephalosporin. The Pediatric infectious disease journal 19(12 Suppl) S141–S146. DOI:10.1097/00006454-200012001-00002 PUBMED:https://pubmed.ncbi.nlm.nih.gov/11144395
Mao, N, et al., & Liu, X (2025). Bioequivalence of cefdinir dispersible tablets in healthy Chinese subjects under fasting and fed conditions: a single-centred, randomized, open, single-dose, two-preparation, two-cycle, two-sequence, double-crossover trial. Naunyn-Schmiedeberg's archives of pharmacology 398(6) 6821–6829. DOI:10.1007/s00210-024-03701-8 PUBMED:https://pubmed.ncbi.nlm.nih.gov/39680100
Pichichero, ME, et al., & Nicolau, DP (2008). Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children. Paediatric drugs 10(6) 391–397. DOI:10.2165/0148581-200810060-00006 PUBMED:https://pubmed.ncbi.nlm.nih.gov/18998749